DataMeds AI, Inc. (MEDS) — Institutional Holders, Q2 2026
10 institutional investment managers reported a MEDS position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $160.6K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
MEDS in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- JANE STREET GROUPAdded · +18,652 sh+$57.8K
- BARCLAYS PLCNew · +723 sh+$2.2K
- Tower Research Capital (TRC)New · +678 sh+$2.1K
- Fortitude Family OfficeNew · +118 sh+$366.00
- Integrated Wealth ConceptsNew · +25 sh+$77.00
Biggest sellers
- STATE STREETSold out · -2,492 sh-$7.7K
- GEODE CAPITAL MANAGEMENTTrimmed · -1,748 sh-$5.4K
- NORTHERNSold out · -1,481 sh-$4.6K
- RAYMOND JAMES FINANCIALSold out · -1,168 sh-$3.6K
- VANGUARD CAPITAL MANAGEMENTTrimmed · -1,000 sh-$3.1K
MEDS 13F holders ranked 1–10 of 10
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | JANE STREET GROUP#1 · 20,532 sh | 20,532 | $63.6K | 0.00% | -78.2% |
| 2 | GEODE CAPITAL MANAGEMENT#2 · 12,467 sh | 12,467 | $38.6K | 0.00% | -98.2% |
| 3 | VANGUARD CAPITAL MANAGEMENT#3 · 11,085 sh | 11,085 | $34.4K | 0.00% | -98.2% |
| 4 | VANGUARD FIDUCIARY#4 · 6,191 sh | 6,191 | $19.2K | 0.00% | -98.0% |
| 5 | BARCLAYS PLC#5 · 723 sh | 723 | $2.2K | 0.00% | New |
| 6 | Tower Research Capital (TRC)#6 · 678 sh | 678 | $2.1K | <0.01% | New |
| 7 | Fortitude Family Office#7 · 118 sh | 118 | $366.00 | — | New |
| 8 | Integrated Wealth Concepts#8 · 25 sh | 25 | $78.00 | 0.00% | New |
| 9 | Global Retirement Partners#9 · 2 sh | 2 | $6.00 | 0.00% | — |
| 10 | DANSKE BANK A/S#10 · 1 sh | 1 | $3.00 | 0.00% | New |
Funds that sold out of MEDS in Q2 2026 (9)
Held MEDS at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| STATE STREET2,492 sh | 2,492 | $12.0K |
| NORTHERN1,481 sh | 1,481 | $7.1K |
| RAYMOND JAMES FINANCIAL1,168 sh | 1,168 | $5.6K |
| ACT Advisors708 sh | 708 | $3.4K |
| XTX Topco Ltd630 sh | 630 | $3.0K |
| Point72 Asset Management, L.P.546 sh | 546 | $2.6K |
| VALLEY FORGE INVESTMENT CONSULTANTS ADV460 sh | 460 | $2.2K |
| AQR CAPITAL MANAGEMENT406 sh | 406 | $2.0K |
| Sentinus406 sh | 406 | $2.0K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.